Company Filing History:
1 out of 10 
1 out of 197 
Years Active: 2024
Title: Gianluigi Taverna: Innovator in Prostate Cancer Risk Assessment
Introduction
Gianluigi Taverna is a notable inventor based in Rozzano, Italy. He has made significant contributions to the field of medical diagnostics, particularly in assessing the risk of prostate cancer. His innovative approach utilizes advanced technology to improve early detection and treatment strategies.
Latest Patents
Gianluigi Taverna holds a patent for "Methods to assess the risk of being affected by prostate cancer." This patent discloses methods for evaluating the risk that a male subject may have prostate cancer and determining the aggressiveness of the cancer. The methods involve analyzing the gaseous headspace of urine samples using at least three metal oxide semiconductor-based gas sensors. The first sensor utilizes pure or doped SnO, the second sensor employs pure or doped ZnO, and the third sensor incorporates pure or doped SnO, pure or doped TiO, and pure or doped NbO.
Career Highlights
Throughout his career, Gianluigi Taverna has worked with reputable organizations, including Humanitas Mirasole S.p.a. and Politecnico di Milano. His work has focused on enhancing diagnostic methods and contributing to the medical field through innovative research.
Collaborations
Gianluigi has collaborated with esteemed colleagues such as Fabio Grizzi and Laura Maria Teresa Capelli. These partnerships have fostered advancements in research and development in the area of prostate cancer diagnostics.
Conclusion
Gianluigi Taverna's contributions to the field of prostate cancer risk assessment highlight his innovative spirit and dedication to improving medical diagnostics. His work continues to pave the way for advancements in early detection and treatment options for prostate cancer.